Provided By GlobeNewswire
Last update: Jun 4, 2025
Southlake, TX, June 04, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (“AI”) powered medical technology company focused on advancing the capabilities of ECGs/EKGs for the earlier detection of heart disease, today announced that the U.S. Food and Drug Administration (“FDA”) has granted Breakthrough Device designation for its Aortic Stenosis (“AS”) ECG algorithm.
Read more at globenewswire.com3.6
-0.11 (-2.96%)
NASDAQ:HSCSW (6/12/2025, 4:00:00 PM)
0.0523
+0 (+0.38%)
Find more stocks in the Stock Screener